Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

Salicylalazine: A Novel Therapeutic Agent Targeting TLR4/NLRP3/GSDMD-Mediated Pyroptosis in Rheumatoid Arthritis

International immunopharmacology | Vol. 145 | 2024

DOI: https://doi.org/10.1016/j.intimp.2024.113778

Synthesis of bis‑thiohydantoin derivatives as an antiproliferative agents targeting EGFR inhibitory pathway

Molecular Diversity | 2023

DOI: https://doi.org/10.1007/s11030-023-10653-3

Synthesis and Antiproliferative Potential of Thiazole and 4- Thiazolidinone Containing Motifs as Dual Inhibitors of EGFR and BRAFV600E

Molecules | 2023

DOI: https://doi.org/10.3390/molecules28247951

Synthesis of bis‑thiohydantoin derivatives as an antiproliferative agents targeting EGFR inhibitory pathway

Molecular Diversity | 2023

DOI: https://doi.org/10.1007/s11030-023-10653-3

Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties

Frontiers in Chemistry | 2022

DOI: https://doi.org/10.3389/fchem.2022.1039176

Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties

Frontiers in Chemistry | 2022

DOI: https://doi.org/10.3389/fchem.2022.1039176

Sodium alginate based drug delivery in management of breast cancer

Carbohydrate Polymers | 2022

DOI: https://doi.org/10.1016/j.carbpol.2022.119689

Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile

Vaccines | 2022

DOI: https://doi.org/10.3390/vaccines10060924

Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians

Metabolites | 2022

DOI: https://doi.org/10.3390/metabo11110794

Structure-based design, synthesis and antiproliferative action of new quizoline-4-one/chalcone hybrids as EGFR inhibitors

Journal of Molecular Structure | 2022

DOI: https://doi.org/10.1016/j.molstruc.2022.132422